InvestorsHub Logo
Followers 19
Posts 218
Boards Moderated 0
Alias Born 03/06/2006

Re: None

Saturday, 07/15/2006 4:13:06 PM

Saturday, July 15, 2006 4:13:06 PM

Post# of 346175
I hope to have conversations soon to clarify and develop certain remarks made in CC.

In the mean time, I note the rumor (not yet confirmed by me) that Company hopes to present HCV repeat dose data at AASLD Annual Meeting in Boston Oct 27-31.

How interesting to see this statement on the web page for that meeting:

https://www.aasld.org/eweb/DynamicPage.aspx?webcode=06_Livermeeting

"Late Breaking Abstracts

Original late-breaking scientific research that was conducted and submitted after June 7, 2006 will be reviewed for presentation at The Liver Meeting."

I ask you, is it just a coincidence that the Company's PR announcing that “enrollment has begun” in HCV repeat dose trial was also dated June 7 ????????

Hmmmmmm.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News